Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) started the day on Wednesday, with a price decrease of -8.34% at $0.81, before settling in for the price of
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) on Friday, plunged -8.00% from the previous trading day, before settling in for the closing price of $1.06. Within the
A new trading day began on Tuesday, with Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) stock price down -6.30% from the previous day of trading, before settling
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) established initial surge of 7.44% at $1.30, before settling in for the price of $1.21 at the close. Taking a
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) kicked off on Friday, down -37.44% from the previous trading day, before settling in for the closing price of $1.95.
On Monday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) opened higher 3.33% from the last session, before settling in for the closing price of $1.80. Price fluctuations
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) flaunted slowness of -1.08% at $1.84, before settling in for the price of $1.86 at the close. Taking a more
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) kicked off on Monday, down -6.25% from the previous trading day, before settling in for the closing price of $2.08.
As on Thursday, Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) got off with the flyer as it spiked 5.24% to $2.01, before settling in for the price
Lexicon is heading towards a big breakthrough as the company obtains key primary endpoints in phase 3 of both the SOLOIST and SCORED studies. Lexicon
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
